Definium, Up 190% This Year, Succeeds Again With Synthetic LSD; Shares Fly

Definium Therapeutics' (DFTX) synthetic LSD eased the symptoms of anxiety, the company said Monday as shares, already up 190% this year, took off again. Patients showed a 9.8-point improvement on a 56-point Hamilton Anxiety Rating Scale 12 weeks after undergoing treatment. In comparison, the placebo group improved by 4.7 points. The effect was rapid, with responses showing as early as…